Citing New Jersey’s interest in ensuring that companies in the state make safe products, the Appellate Division has reinstated a suit by an out-of-state man who claimed Hoffmann-La Roche’s acne drug Accutane caused him to become so depressed that he attempted suicide.
The judges reversed a lower court’s ruling that because the plaintiff is from Michigan, that state’s product liability statute should control. Michigan offers almost absolute immunity for companies if the drug has U.S. Food and Drug Administration approval.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
